Tsuneo Ito

781 citations
23 papers · 548 indexed · h-index 9
Topics
Neuroblastoma Research and Treatments (3 papers)Mesenchymal stem cell research (2 papers)Tissue Engineering and Regenerative Medicine (2 papers)

In The Last Decade

Tsuneo Ito

19 papers receiving 528 citations

Peers

Tsuneo Ito
Comparison fields: 5 of 81
  • Epidemiology 306
  • Molecular Biology 148
  • Hepatology 120
  • Endocrinology, Diabetes and Metabolism 104
  • Surgery 63
Replace Toshiyuki Uchikoshi with:
Toshiyuki Uchikoshi Japan
Yosuke Aihara Japan
Daniel A. Giles United States
Yih-Hsin Chang Taiwan
Ali Rıza Köksal Türkiye
Ewa Gruszewska Poland
Tatsuya Itoshima Japan
Hong Jun Kim South Korea
Nirupma Trehanpati India
Agnieszka Adamek Poland
Tsuneo Ito relative to Toshiyuki Uchikoshi Japan Toshiyuki Uchikoshi's profile →
Citations per field
00.5×7.6×
Toshiyuki Uchikoshi · 1×
Citations per year

Countries citing papers authored by Tsuneo Ito

Since Specialization
Citations

This map shows the geographic impact of Tsuneo Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuneo Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuneo Ito more than expected).

Fields of papers citing papers by Tsuneo Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuneo Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuneo Ito. The network helps show where Tsuneo Ito may publish in the future.

Co-authorship network of co-authors of Tsuneo Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuneo Ito. A scholar is included among the top collaborators of Tsuneo Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuneo Ito. Tsuneo Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2 9
3 20
4 361
5 3
6 1
7 2
8 6
9 33
10 0
11 4
12 4
13 2
14 48
15 0
16 4
17 12
18 0
19 4
20 1

About Tsuneo Ito

Tsuneo Ito is a scholar working on Pharmaceutical Science, Obstetrics and Gynecology and Hepatology, having authored 23 papers that have together received 548 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (3 papers), Mesenchymal stem cell research (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). The work is most often cited by research in Hepatology (120 citations), Epidemiology (306 citations) and Endocrinology, Diabetes and Metabolism (104 citations). Tsuneo Ito has collaborated with scholars based in Japan, United States and Nigeria. Frequent co-authors include Masahiko Matsumoto, Yoshiyuki Sakamaki, Chiaki Tanaka, Akiko Uno, Masayuki Sudoh, Natsuko Hada, Tetsuro Sugimoto, Shizuo Yamamoto, Toshio Mori and Hiroyuki Arai. Their work appears in journals such as Scientific Reports, Human Reproduction and Biology of Reproduction.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026